• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CDISC names additions to board of directors

CDISC names additions to board of directors

January 25, 2013
CenterWatch Staff

CDISC, a global, open, non-profit organization that has established standards to support the acquisition, exchange, submission and archive of clinical research data and metadata, has named five highly qualified individuals that will add invaluable expertise to the CDISC board of directors (BoD) for a three-year term beginning this month (2013–2016): Dr. Carolyn Compton, Michael Glickman, Dr. Douglas Peddicord, Stephen Pyke and John Speakman.

Carolyn Compton, M.D. and Ph.D., is the current president and CEO of the Critical Path Institute (C-Path), which is partnered with CDISC through the Coalition For Accelerating Standards and Therapies (CFAST) and other initiatives through which the CDISC Alzheimer’s disease and tuberculosis standards were developed. Compton served for 15 years as the director of gastrointestinal pathology at the Massachusetts General Hospital, as a professor of pathology at Harvard Medical School and the chair of pathology and pathologist-in-chief at McGill University Health Center. Before taking on her current role at C-Path, she served as director of the Office of Biorepositories and Biospecimen Research and the executive director of the Cancer Human Biobank Project at the National Cancer Institute.

Michael Glickman, MSE, is the founder and president of Computer Network Architects, through which he has worked with hundreds of healthcare organizations and has experience with every popular EHR system currently available. He has over 45 years of experience in the computer industry, and during the last 35 years has specialized in the unique problems of systems integration in healthcare. His HIT expertise includes EHRs, Continuity of Care Record (CCR) integration, server consolidation, including “clinically reliable” business continuity/disaster recovery (BC/DR), enterprise PACS via enterprise SANs for all modalities, LAN/WAN/MAN technologies, voice convergence including unified communications (UC), patient care devices (PCD) and Health Information Exchange (HIE). Glickman was a founding member of the HL7 Working Group and currently serves as chair of the U.S. Technical Advisory Group to ISO TC215 Health Informatics.

Douglas Peddicord, Ph.D., serves as executive director of the Association of Clinical Research Organizations (ACRO), which has been a major supporter of CDISC and the move toward clinical data standards to improve the quality and efficiency of clinical trials. He is also president of Washington Health Strategies Group, which provides a full range of strategic consulting, government affairs and association management services to healthcare organizations. His particular areas of expertise include health information technology and medical privacy, clinical trials, medical informatics and Medicare coverage and payment policy.

Stephen Pyke serves as the vice president of quantitative sciences at GlaxoSmithKline, with 17 years experience in the pharmaceutical industry. In his current role, Pyke leads a multidisciplinary group of 600 quantitative scientists spanning statistics and programming, clinical pharmacology modeling and simulation, epidemiology, genetics and computational biology. He has also held a number of honorary positions including past-chair and board member of Statisticians in the Pharmaceutical Industry (PSI), and is currently vice president and council member of the Royal Statistical Society.

John Speakman serves as senior director of research information technology for the New York University (NYU) Langone Medical Center.  He joined NYU in July 2012. Speakman collaborates with the research community both at NYU and beyond with the goal of connecting people and technology to further the research mission of the Center in basic science, clinical trials, investigator-initiated and sponsored projects.  Previously, he served at the National Cancer Institute (NCI) as chief program officer for the Center for Biomedical Informatics and Information Technology. Speakman was re-elected to the CDISC board this year after serving in 2012.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing